Kalehua Capital Management LLC Top Holdings and 13F Report (2026) About Kalehua Capital Management LLCInvestment ActivityKalehua Capital Management LLC has $173.96 million in total holdings as of June 30, 2026.Kalehua Capital Management LLC owns shares of 26 different stocks, but just 13 companies or ETFs make up 80% of its holdings.Approximately 26.03% of the portfolio was purchased this quarter.About 17.19% of the portfolio was sold this quarter.This quarter, Kalehua Capital Management LLC has purchased 25 new stocks and bought additional shares in 3 stocks.Kalehua Capital Management LLC sold shares of 2 stocks and completely divested from 7 stocks this quarter.Largest Holdings Alpha Architect 1-3 Month Box ETF $26,484,353Veradermics Inc $17,911,743X4 Pharmaceuticals Inc $17,385,663Compass Pathways $11,598,642Surrozen Inc $9,995,369 Largest New Holdings this Quarter 48576U205 - Karyopharm Therapeutics Inc $6,698,742 HoldingN44821101 - InflaRx $6,491,003 Holding23255M204 - Cyclerion Therapeutics $5,598,077 Holding00704R109 - Adlai Nortye $2,603,773 Holding67080T108 - Nuvectis Pharma $1,839,000 Holding Largest Purchases this Quarter Alpha Architect 1-3 Month Box ETF 126,332 shares (about $14.79M)Karyopharm Therapeutics Inc 685,644 shares (about $6.70M)InflaRx 2,897,769 shares (about $6.49M)Cyclerion Therapeutics 1,651,350 shares (about $5.60M)Korro Bio Inc 295,664 shares (about $3.90M) Largest Sales this Quarter uniQure 211,702 shares (about $9.75M)Instil Bio Inc 83,430 shares (about $641.58K) Sector Allocation Over TimeMap of 500 Largest Holdings ofKalehua Capital Management LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorBOXXAlpha Architect 1-3 Month Box ETF$26,484,353$14,792,214 ▲126.5%226,18815.2%ETFVeradermics Inc$17,911,7430.0%145,69510.3%COMMON STOCKX4 Pharmaceuticals Inc$17,385,6630.0%3,722,84010.0%COM NEWCMPSCompass Pathways$11,598,6420.0%819,6926.7%HealthcareSurrozen Inc$9,995,3690.0%385,1785.7%COM NEWACRSAclaris Therapeutics$9,693,2110.0%1,832,3655.6%HealthcareSionna Therapeutics Inc$8,669,1970.0%197,0725.0%COMInhibikase Therapeutics Inc$7,758,4370.0%3,821,8904.5%COM NEWPHVSPharvaris$6,873,5360.0%198,7724.0%HealthcareKaryopharm Therapeutics Inc$6,698,742$6,698,742 ▲New Holding685,6443.9%COM NEWSepterna Inc$6,515,2790.0%194,5443.7%COMIFRXInflaRx$6,491,003$6,491,003 ▲New Holding2,897,7693.7%HealthcareCYCNCyclerion Therapeutics$5,598,077$5,598,077 ▲New Holding1,651,3503.2%HealthcareKorro Bio Inc$5,338,427$3,896,851 ▲270.3%405,0403.1%COMQUREuniQure$3,657,486$9,750,993 ▼-72.7%79,4072.1%HealthcareLeonaBio Inc$3,618,1120.0%393,7012.1%COMDamora Therapeutics Inc$3,615,3900.0%139,0002.1%COM NEWMLTXMoonLake Immunotherapeutics$3,421,5410.0%175,7342.0%HealthcareAdlai Nortye$2,603,773$2,603,773 ▲New Holding226,4151.5%SPONSORED ADSTYRATyra Biosciences$2,378,4120.0%74,4651.4%HealthcareNVCTNuvectis Pharma$1,839,000$1,839,000 ▲New Holding100,0001.1%HealthcareGOSSGossamer Bio$1,835,185$150,291 ▲8.9%11,149,3631.1%HealthcareMISTMilestone Pharmaceuticals$1,700,778$1,700,778 ▲New Holding1,269,2371.0%HealthcareLIFEEthos Technologies Inc. Class A Common Stock$1,067,178$1,067,178 ▲New Holding1,788,1670.6%FinanceInstil Bio Inc$765,924$641,577 ▼-45.6%99,6000.4%COM NEWTCRXTScan Therapeutics$445,824$445,824 ▲New Holding454,8760.3%HealthcareRLAYRelay Therapeutics$0$8,969,497 ▼-100.0%00.0%HealthcareOruka Therapeutics Inc$0$5,813,602 ▼-100.0%00.0%COMPEPGPepGen$0$1,770,000 ▼-100.0%00.0%HealthcareTNYATenaya Therapeutics$0$1,384,800 ▼-100.0%00.0%HealthcareKalaris Therapeutics Inc$0$782,325 ▼-100.0%00.0%COMDMACDiaMedica Therapeutics$0$423,044 ▼-100.0%00.0%HealthcareLOOPLoop Industries$0$361,441 ▼-100.0%00.0%MaterialsShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
